Lung ultrasound and biomarkers in primary care: Partners for a better management of patients with heart failure?

Q3 Medicine
Journal of Circulating Biomarkers Pub Date : 2020-10-16 eCollection Date: 2020-01-01 DOI:10.33393/jcb.2020.2164
Mar Domingo, Laura Conangla, Josep Lupón, Asunción Wilke, Gladys Juncà, Elena Revuelta-López, Xavier Tejedor, Antoni Bayes-Genis
{"title":"Lung ultrasound and biomarkers in primary care: Partners for a better management of patients with heart failure?","authors":"Mar Domingo,&nbsp;Laura Conangla,&nbsp;Josep Lupón,&nbsp;Asunción Wilke,&nbsp;Gladys Juncà,&nbsp;Elena Revuelta-López,&nbsp;Xavier Tejedor,&nbsp;Antoni Bayes-Genis","doi":"10.33393/jcb.2020.2164","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The association of pulmonary congestion assessed by lung ultrasound (LUS) and biomarkers-other than N-terminal pro-brain natriuretic peptide (NT-proBNP)-is uncertain.</p><p><strong>Methods: </strong>We investigated the relationship between total B-line count by LUS and several biomarkers in outpatients with suspicion of heart failure (HF). Primary care patients with suspected new-onset nonacute HF were evaluated both with a 12-scan LUS protocol (8 anterolateral areas plus 4 lower posterior thoracic areas) and 11 inflammatory and cardiovascular biomarkers. A cardiologist blinded to LUS and biomarkers except NT-proBNP confirmed HF diagnosis. After log-transformation of biomarkers' concentrations, unadjusted and adjusted correlations were performed.</p><p><strong>Results: </strong>A total of 170 patients were included (age 76 ± 10 years, 67.6% women). HF diagnosis was confirmed in 38 (22.4%) patients. After adjustment by age, sex, body mass index, and renal function, total B-line sum significantly correlated with NT-proBNP (R = 0.29, p < 0.001), growth/differentiation factor-15 (GDF-15; R = 0.23, p = 0.003), high-sensitive Troponin T (hsTnT; R = 0.36, p < 0.001), soluble interleukin-1 receptor-like 1 (sST2; R = 0.29, p < 0.001), cancer antigen 125 (CA-125; R = 0.17, p = 0.03), high-sensitivity C-reactive protein (hsCRP; R = 0.20, p = 0.009), and interleukin (IL)-6 (R = 0.23, p = 0.003). In contrast, IL-33 (R = -0.01, p = 0.93), IL-1β (R = -0.10, p = 0.20), soluble neprilysin (sNEP; R = 0.09, p = 0.24), tumor necrosis factor-alpha (TNF-α; R = 0.07, p = 0.39), and TNF-α receptor superfamily member 1A (TNFRSF1A; R = 0.14, p = 0.07) did not.</p><p><strong>Conclusions: </strong>Total B-line sum correlated significantly, although moderately, with congestion and several inflammation biomarkers. Unexpectedly, the highest correlation found was with hsTnT.</p>","PeriodicalId":37524,"journal":{"name":"Journal of Circulating Biomarkers","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0f/57/JCB-9-8.PMC7951183.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Circulating Biomarkers","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33393/jcb.2020.2164","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 4

Abstract

Introduction: The association of pulmonary congestion assessed by lung ultrasound (LUS) and biomarkers-other than N-terminal pro-brain natriuretic peptide (NT-proBNP)-is uncertain.

Methods: We investigated the relationship between total B-line count by LUS and several biomarkers in outpatients with suspicion of heart failure (HF). Primary care patients with suspected new-onset nonacute HF were evaluated both with a 12-scan LUS protocol (8 anterolateral areas plus 4 lower posterior thoracic areas) and 11 inflammatory and cardiovascular biomarkers. A cardiologist blinded to LUS and biomarkers except NT-proBNP confirmed HF diagnosis. After log-transformation of biomarkers' concentrations, unadjusted and adjusted correlations were performed.

Results: A total of 170 patients were included (age 76 ± 10 years, 67.6% women). HF diagnosis was confirmed in 38 (22.4%) patients. After adjustment by age, sex, body mass index, and renal function, total B-line sum significantly correlated with NT-proBNP (R = 0.29, p < 0.001), growth/differentiation factor-15 (GDF-15; R = 0.23, p = 0.003), high-sensitive Troponin T (hsTnT; R = 0.36, p < 0.001), soluble interleukin-1 receptor-like 1 (sST2; R = 0.29, p < 0.001), cancer antigen 125 (CA-125; R = 0.17, p = 0.03), high-sensitivity C-reactive protein (hsCRP; R = 0.20, p = 0.009), and interleukin (IL)-6 (R = 0.23, p = 0.003). In contrast, IL-33 (R = -0.01, p = 0.93), IL-1β (R = -0.10, p = 0.20), soluble neprilysin (sNEP; R = 0.09, p = 0.24), tumor necrosis factor-alpha (TNF-α; R = 0.07, p = 0.39), and TNF-α receptor superfamily member 1A (TNFRSF1A; R = 0.14, p = 0.07) did not.

Conclusions: Total B-line sum correlated significantly, although moderately, with congestion and several inflammation biomarkers. Unexpectedly, the highest correlation found was with hsTnT.

初级保健中的肺超声和生物标志物:对心力衰竭患者更好管理的伙伴?
肺超声(LUS)评估的肺充血与生物标志物(除了n端脑利钠肽前体(NT-proBNP))的关系是不确定的。方法:我们研究了怀疑心力衰竭(HF)的门诊患者LUS总b线计数与几种生物标志物之间的关系。怀疑新发非急性心力衰竭的初级保健患者通过12次扫描LUS方案(8个前外侧区域加上4个胸后下部区域)和11个炎症和心血管生物标志物进行评估。一位对LUS和除NT-proBNP外的生物标志物不知情的心脏病专家证实了HF的诊断。在对生物标志物浓度进行对数转换后,进行未调整和调整的相关性。结果:共纳入170例患者(年龄76±10岁,67.6%为女性)。38例(22.4%)患者确诊HF。经年龄、性别、体重指数和肾功能调整后,b线总金额与NT-proBNP (R = 0.29, p < 0.001)、生长/分化因子-15 (GDF-15;R = 0.23, p = 0.003),高敏感肌钙蛋白T (hsTnT;R = 0.36, p < 0.001),可溶性白细胞介素-1受体样1 (sST2;R = 0.29, p < 0.001),癌抗原125 (CA-125;R = 0.17, p = 0.03),高敏c反应蛋白(hsCRP;R = 0.20, p = 0.009)和白细胞介素(IL)-6 (R = 0.23, p = 0.003)。相比之下,IL-33 (R = -0.01, p = 0.93)、IL-1β (R = -0.10, p = 0.20)、可溶性溶血素(sNEP;R = 0.09, p = 0.24),肿瘤坏死因子α (TNF-α;R = 0.07, p = 0.39), TNF-α受体超家族成员1A (TNFRSF1A;R = 0.14, p = 0.07)。结论:b线总金额与充血和几种炎症生物标志物显著相关,尽管相关性不大。出乎意料的是,与hsTnT的相关性最高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Circulating Biomarkers
Journal of Circulating Biomarkers Medicine-Biochemistry (medical)
CiteScore
3.20
自引率
0.00%
发文量
9
审稿时长
8 weeks
期刊介绍: Journal of Circulating Biomarkers is an international, peer-reviewed, open access scientific journal focusing on all aspects of the rapidly growing field of circulating blood-based biomarkers and diagnostics using circulating protein and lipid markers, circulating tumor cells (CTC), circulating cell-free DNA (cfDNA) and extracellular vesicles, including exosomes, microvesicles, microparticles, ectosomes and apoptotic bodies. The journal publishes high-impact articles that deal with all fields related to circulating biomarkers and diagnostics, ranging from basic science to translational and clinical applications. Papers from a wide variety of disciplines are welcome; interdisciplinary studies are especially suitable for this journal. Included within the scope are a broad array of specialties including (but not limited to) cancer, immunology, neurology, metabolic diseases, cardiovascular medicine, regenerative medicine, nosology, physiology, pathology, technological applications in diagnostics, therapeutics, vaccine, drug delivery, regenerative medicine, drug development and clinical trials. The journal also hosts reviews, perspectives and news on specific topics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信